Lot-specific analytical review.
Exact-lot analytical results are documented and reviewed before a released lot is made available for purchase.
Research Compound · RUO
Released
Lot GHK-CU-26-001·100 mg·Released September 21, 2026
GHK-Cu 100 mg
$125.00
GHK-Cu 100 mg
Research material · Current lotGHK-CU-26-001
Lot-specific analytical documentation maintained through the
Osmora Quality system.
Research Use Only.
Not for human or veterinary use.
Availability:Available for Purchase
Lot Release EvidenceReleased
9/9Core Release Checks Passed
1:1 TraceabilityVial QR → GHK-CU-26-001 → Public Record
Exact lotDocumentationFreedom Diagnostics
Third-partyView all 9 completed core checks
01Identity Confirmation✓
02HPLC / UPLC Purity✓
03Vial Content / Quantity✓
04Bacterial Endotoxin✓
05PCR Microbial Screening✓
06Elemental Impurities✓
07Fentanyl Screening✓
08pH Analysis✓
09Documented Appearance✓
9 Core + 7 ExtendedExtended analyses are documented separately from the release gate and are only represented as complete when exact-lot evidence is published.
Verify This VialRESEARCH USE ONLY
All Products listed on this site are for research purposes only.
Original source documentOriginal Lab ReportOpen the original third-party report connected to this exact lot.1:1 lot verificationVerify This VialFollow the vial QR to this exact lot's public batch record and published evidence.MethodologyUnderstand the TestingLearn what the analytical checks mean and how Osmora releases lots.
Processing1–2 business daysAfter payment and required order review.
TrackingEmail updatesTracking is sent after postage is purchased or the carrier accepts the shipment.
Loss or damageReplacement after verificationVerified carrier loss or transit damage is handled under the Shipping Policy.
Research supportContact Osmora →Order and documentation questions.
Technical specification
For laboratory research use only. Not for human or veterinary use.
For laboratory research use only. Not for human or veterinary use.
Current lot · GHK-CU-26-001
RELEASED
Core release testing complete · QA approved
Core Release Standard
9/9 PASS
HPLC / UPLC Purity
99.96%
Vial Content / Quantity
100.96 mg
Identity
GHK-Cu — Confirmed
View complete batch record →
Extended framework: 0/7 documented
9/9Core release checks passed
9 + 7Core release + extended analytical checks
1:1Vial QR → exact lot → public batch record
Freedom DiagnosticsAnalytical documentation source
Documentation-first purchasing.
- 1:1 lot traceability connects the vial QR, exact lot identity, public batch record, release decision, and published evidence.
- 9/9 core release checks passed before a released lot is made available for purchase.
- 9 core release checks are separated from 7 extended analytical checks, so planned work is not presented as completed release evidence.
- Research Use Only — not for human or veterinary use.
The Osmora model
Built around the record, not just the vial.
The material is one part of the system. Osmora also maintains the analytical, traceability, documentation and review infrastructure surrounding each released lot.
1:1 vial-to-lot connection.
The vial QR connects the physical vial to its exact lot identity, public batch record, release decision and published evidence.
A record designed to remain inspectable.
Original source documents, laboratory attribution, accession data, record history and integrity controls stay connected to the lot record.
9/9 is necessary—not the whole gate.
Final release also depends on documentation, batch traceability, exception controls and completed QA review within Osmora's QMS.
This lot cleared Osmora's release gate and is linked to lot-specific documentation.
GHK-Cu 100 mg
Research material · Current lotGHK-CU-26-001
Lot-specific analytical documentation maintained through the
Osmora Quality system.
Research Use Only.
Not for human or veterinary use.
GHK-Cu 100 mgresearch material from current lot
GHK-CU-26-001.
Nominal Content
100 mg
Current Lot
GHK-CU-26-001
Research Classification
Research Use Only
Each Osmora lot is documented through a lot-specific quality record.
The current batch has completed Osmora's 9-Check Core Release Standard,
while additional analytical characterization is tracked separately
within the Extended Analytical Framework.
Documentation-First Research Material
Osmora Research maintains lot-specific analytical records so researchers
can review the testing associated with the material they receive rather
than relying on a generic or reused certificate.
Analytical results, laboratory attribution, methods, source documentation,
and current lot status are maintained through the Osmora Quality system
and public verification record.
Research Use Only.
Not for human or veterinary use. For laboratory and analytical research
purposes only.
Current status:Released · Lot GHK-CU-26-001
Orders ship within 1–2 business days to all 50 U.S. states unless otherwise noted at checkout. Carrier-verified lost or damaged shipments are eligible for replacement after verification.
All Osmora products are sold strictly for laboratory research use only. They are not for human use, animal use, therapeutic use, diagnostic use, compounding, or veterinary use.
Related products
NAD+
$180.00Glutathione
$85.00TB-500
$95.00
